Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
61,488.53 +617.51 (+1.01%) CMC Crypto 200
1,274.17 -9.66 (-0.75%)
X4 Pharmaceuticals, Inc. (XFOR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 97.40M |
| Enterprise value | 74.81M |
| Trailing P/E | 5.49 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 94.02 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.94 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.40 |
| 52-week change 3 | -69.15% |
| S&P500 52-week change 3 | 22.55% |
| 52-week high 3 | 2.0600 |
| 52-week low 3 | 0.5700 |
| 50-day moving average 3 | 1.0288 |
| 200-day moving average 3 | 0.9525 |
Share statistics
| Avg vol (3-month) 3 | 3.1M |
| Avg vol (10-day) 3 | 4.23M |
| Shares outstanding 5 | 167.94M |
| Implied shares outstanding 6 | 167.94M |
| Float 8 | 127.86M |
| % held by insiders 1 | 1.15% |
| % held by institutions 1 | 67.59% |
| Shares short (14 Jun 2024) 4 | 11.92M |
| Short ratio (14 Jun 2024) 4 | 9.38 |
| Short % of float (14 Jun 2024) 4 | 7.16% |
| Short % of shares outstanding (14 Jun 2024) 4 | 7.10% |
| Shares short (prior month 15 May 2024) 4 | 12.21M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 14 Mar 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:6 |
| Last split date 3 | 14 Mar 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -61.03% |
| Return on equity (ttm) | -489.12% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -115.15M |
| Net income avi to common (ttm) | -128.91M |
| Diluted EPS (ttm) | -0.6700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 80.87M |
| Total cash per share (mrq) | 0.48 |
| Total debt (mrq) | 58.27M |
| Total debt/equity (mrq) | 5,625.00% |
| Current ratio (mrq) | 3.71 |
| Book value per share (mrq) | 0.01 |
Cash flow statement
| Operating cash flow (ttm) | -103.6M |
| Levered free cash flow (ttm) | -63.29M |
© 2024 Yahoo. All rights reserved.